We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$37.1B
AUM Growth
+$3.51B
(+10%)
Cap. Flow
+$2.36B
Cap. Flow
% of AUM
6.37%
Top 10 Holdings %
Top 10 Hldgs %
44.48%
Holding
300
New
13
Increased
121
Reduced
73
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$224M |
| 2 |
TSMC
TSM
|
+$215M |
| 3 |
Apple
AAPL
|
+$203M |
| 4 |
Procter & Gamble
PG
|
+$179M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$407M |
| 2 |
Air Products & Chemicals
APD
|
+$178M |
| 3 |
RTX Corp
RTX
|
+$153M |
| 4 |
T. Rowe Price
TROW
|
+$63.3M |
| 5 |
Marriott International
MAR
|
+$54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.26% |
| 2 | Financials | 17.13% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Staples | 11.47% |
| 5 | Energy | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Progressive
PGR
$126B
| $456M | 1.23% |
2,196,271
+35,822
| +2% | +$7.5M |
|
27
Abbott
ABT
$176B
| $429M | 1.16% |
4,130,719
+101,432
| +3% | +$10.8M |
|
28
Chubb
CB
$130B
| $399M | 1.08% |
1,562,540
+541,267
| +53% | +$139M |
|
29
Merck
MRK
$355B
| $362M | 0.98% |
2,921,940
+718,344
| +33% | +$92.5M |
|
30
Canadian Pacific Kansas City
CP
$78.4B
| $358M | 0.97% |
4,542,828
+446,145
| +11% | +$36.3M |
|
31
AbbVie
ABBV
$454B
| $348M | 0.94% |
2,028,833
+103,709
| +5% | +$17.2M |
|
32
Meta Platforms (Facebook)
META
$1.7T
| $344M | 0.93% |
681,457
+127,760
| +23% | +$62.1M |
|
33
NVIDIA
NVDA
$5.09T
| $332M | 0.89% |
2,684,038
+1,227,848
| +84% | +$124M |
|
34
Automatic Data Processing
ADP
$110B
| $306M | 0.83% |
1,283,280
+122,608
| +11% | +$30.1M |
|
35
Adobe
ADBE
$106B
| $301M | 0.81% |
542,270
+67,898
| +14% | +$32.9M |
|
36
Intercontinental Exchange
ICE
$88.4B
| $301M | 0.81% |
2,199,599
+47,041
| +2% | +$6.32M |
|
|
HES
37
DELISTED
Hess
HES
| $301M | 0.81% |
2,037,477
-2,657,530
| -57% | -$407M |
|
38
Eli Lilly
LLY
$1.01T
| $300M | 0.81% |
331,739
+25,270
| +8% | +$20.2M |
|
|
39
TSMC
TSM
$2.17T
| $288M | 0.78% |
1,657,634
+1,418,098
| +592% | +$215M |
|
40
CME Group
CME
$99.1B
| $268M | 0.72% |
1,364,087
+225,024
| +20% | +$46.5M |
|
41
Altria Group
MO
$118B
| $267M | 0.72% |
5,857,048
-291,517
| -5% | -$12.9M |
|
42
Mondelez International
MDLZ
$79.7B
| $255M | 0.69% |
3,891,097
-301,921
| -7% | -$20.7M |
|
43
AstraZeneca
AZN
$254B
| $253M | 0.68% |
1,619,588
+124,471
| +8% | +$18.7M |
|
44
Comcast
CMCSA
$89.4B
| $252M | 0.68% |
6,438,184
-967,816
| -13% | -$37.9M |
|
|
45
Marriott International
MAR
$87.3B
| $250M | 0.68% |
1,035,648
-225,103
| -18% | -$54M |
|
46
Berkshire Hathaway Class B
BRK.B
$1.09T
| $225M | 0.61% |
554,281
+232,855
| +72% | +$95.1M |
|
|
47
Berkshire Hathaway Class A
BRK.A
$1.09T
| $222M | 0.6% |
363
-10
| -3% | -$6.16M |
|
48
Linde
LIN
$214B
| $216M | 0.58% |
491,278
+51,450
| +12% | +$22.6M |
|
49
ServiceNow
NOW
$147B
| $205M | 0.55% |
1,300,645
+621,535
| +92% | +$91.2M |
|
50
Sherwin-Williams
SHW
$78.5B
| $204M | 0.55% |
682,651
+37,945
| +6% | +$11.7M |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Fayez Sarofim & Co held 300 positions worth $37.1B, up 10% from $33.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Fayez Sarofim & Co deployed $2.36B of net new capital in Q2 2024, opening 13 new positions and adding to 121 existing holdings. Its largest new stake was CoStar Group: 1,407,801 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Hess, an estimated $407M trimmed.
- Fayez Sarofim & Co's largest Q2 2024 buy was CoStar Group: 1,407,801 shares worth $104M.
- Fayez Sarofim & Co added most to Microsoft in Q2 2024, an estimated $224M increase.
- Fayez Sarofim & Co's biggest Q2 2024 reduction was Hess, cutting an estimated $407M.
- Fayez Sarofim & Co fully exited Sable Offshore Corp in Q2 2024, selling an estimated $32.9M.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $37.1B portfolio in Q2 2024.
- Fayez Sarofim & Co opened 13 new positions and closed 22 in Q2 2024.
- Fayez Sarofim & Co's portfolio value rose 10% quarter-over-quarter to $37.1B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2024, filed 14 Aug 2024.